Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 10,959

Document Document Title
WO/2012/085474A1
The present invention relates to a process for preparing chiral amino acids with excellent enantiomeric excesses.  
WO/2012/087182A2
The invention relates to novel substituted methyl amines, serotonin 5-HT6 receptor antagonists, active ingredients, pharmaceutical compositions and a method for preventing and treating diseases of the central nervous system, as well as t...  
WO/2012/082551A2
Described herein is a composition according to formula I or its precursor, formula II: CX1X3=CX2-(R1)p-CZ1 Z2-SO2M (I) wherein X1, X2, and X3 are independently selected from H, F, Cl, Br, I, CF3 and CH3, and wherein at least one of X1, X...  
WO/2012/081488A1
[Problem] To provide an acid catalyst which can reduce the quantity of waste in an organic synthesis reaction and which does not corrode a reactor and is nontoxic. [Solution] The problem is resolved by using a bis(trifluoromethanesulfony...  
WO/2012/072489A1
The invention relates to novel alpha,beta-unsaturated imines, to a method for producing same, to the use thereof for combating animal pests, including anthropods and in particular insects, and to the use thereof in vector control.  
WO/2012/069421A1
Compounds of general formula (I) their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroid...  
WO/2012/026813A3
The invention relates to novel therapeutic compounds, more in particular to biologically active analogs of geranylgeranylacetone (GGA), and various use thereof. Provided is a compound of the general formula (II) and uses thereof as medic...  
WO/2012/042532A4
Processes for the preparation of N-[4-cyano-3-(trifluoro methyl) phenyl]-3-[(4-fluorophenyl) sulphonyl]-2-hydroxy-2- methyl propanamide or Bicalutamide are provided. A method for purifying the Bicalutamide using ethyl acetate solvent res...  
WO/2012/061926A1
The invention relates to bisarylsulfone and dialkylarylsulfone compounds (e.g., compounds according to any of Formulas (I)-(IX) or compounds (1)-(227) of Tables 4 and 5) useful in treating conditions associated with calcium channel funct...  
WO/2011/055381A8
The invention relates to the removal of the impact-sensitive and hazardous sodium azide (NaN3) salt along with ammonium chloride (NH4Cl) for the recovery of dimethyl sulfoxide (DMSO) solvent present in a pharmaceutical industrial effluen...  
WO/2012/055034A1
Compounds of Formula I are disclosed: wherein L, A, R1, R2, R3A, R3B, R4A, R4B, R5, R6 and R7 are defined herein. The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be...  
WO/2012/054526A2
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administering a composition comprising a chemosensory rece...  
WO/2012/054521A2
The present application describes compounds of Formula I and Formula IA and as disclosed herein, that are useful as anti-microbial agents, including as antibacterial, disinfectant, antifungal, germicidal or antiviral agents.  
WO/2012/046771A1
The inventors have intensively studied on compounds that have Aβ42 production inhibitory activity and have found that a compound (I) of the present invention, wherein a carboxylic acid or a tetrazole group is bonded to a cycloalkane moi...  
WO/2012/042532A1
Processes for the preparation of N-[4-cyano-3-(trifluoro methyl) phenyl]-3-[(4-fluorophenyl) sulphonyl]-2-hydroxy-2- methyl propanamide or Bicalutamide are provided. A method for purifying the Bicalutamide using ethyl acetate solvent res...  
WO/2011/071951A3
The invention provides certain N-acyloxysulfonamide and N-hydroxy-N-acylsulfonamide derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions....  
WO/2012/034472A1
Cyano benzenedicarboxamide compounds of formula (I), preparing methods and as agricultural insecticides uses thereof. The compounds have broad-spectrum insecticidal activities.  
WO/2012/036257A1
Provided is a composition for maintaining platelet function that has as the active ingredient a compound represented by general formula (I) [in the formula: X indicates a phenylene group; Y indicates a hydrogen atom or -(CH2)mR1; m indic...  
WO/2012/032534A2
The present invention relates to Furanose derivatives and their applications in synthesis of statins.  
WO/2012/033225A1
The present invention relates to a novel method for producing a pyridazinone compound and an intermediate thereof as shown in the following scheme: wherein the symbols are as defined in the specification.  
WO/2012/031196A1
The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An embodiment of the invention is the provision of a compound of Formula IIIA.  
WO/2012/026813A2
The invention relates to novel therapeutic compounds, more in particular to biologically active analogs of geranylgeranylacetone (GGA), and various use thereof. Provided is a compound of the general formula (II) and uses thereof as medic...  
WO/2011/129967A3
The description includes materials that may be useful for fuel cell applications such as in the manufacture of fuel cell electrodes, proton exchange membranes (PEM), as catalyst additives or in tie layers designed to be thermally and che...  
WO/2012/020483A1
A 3-aminooxalyl aminobenzamide derivative used in an insecticide and miticide is provided. The 3-aminooxalyl aminobenzamide derivative is represented by the following formula. (In the formula, R1 represents a C1 to C3 halo alkylthio grou...  
WO/2012/004443A8
The invention relates to compounds which are active pharmaceutical principles used for treating and/or preventing inflammation and/or cancer, having formula (I) in which -X- is a single bond, -NH- or -CO-, and -Ar is an aromatic radical ...  
WO/2012/016779A1
Sulphur-containing and sulphone-containing aromatic perfluoroalkane monomer that can be used for the manufacture of a polymer membrane intended for a fuel cell of PEM type, said functionalized monomer corresponding to the formula (I): E1...  
WO/2012/010575A1
The invention relates to (4-halogenalkyl-3-thiobenzoyl)cyclohexanediones of general formula (I) and to the use thereof as herbicides. In said formula (I), X, Y, R1, R2, R3 and R4 represent radicals such as hydrogen and organic radicals s...  
WO/2012/010574A1
The invention relates to (4-trifluormethyl-3-thiobenzoyl)cyclohexanediones of general formula (I) and use thereof as herbicides. In said formula (I) X, R1, R2, R3 and R4 represent radicals such as hydrogen and organic radicals such as al...  
WO/2012/010644A1
Process for the synthesis of an isothiocyanate of general formula (I) SCN‑R1-R4-R2 in which R1 and R2 represent, independently of one another, an alkyl, aryl or alkylaryl group, R4 represents a carbonyl, sulphinyl or sulphonyl group or...  
WO/2012/011125A1
The present invention relates to compounds that have the ability to modulate the activity of GPR40 and are therefore useful in the treatment of GPR40 related disorders. In addition the invention relates to the compounds, methods for thei...  
WO/2012/007644A1
The invention relates to novel arylamide derivatives having formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, where R1 - R11, R', R", z and X are as defined in the claims. The arylamide derivatives of formula (...  
WO/2012/008435A1
Disclosed is a novel biaryl amide derivative represented by formula (1) and having an affinity for the aldosterone receptor; also disclosed is a pharmaceutically acceptable salt thereof. (In the formula, A is any of the groups represente...  
WO/2012/005229A1
Disclosed is a compound which is represented by general formula (I) and has an inhibitory effect on ADAM17, a salt thereof, or a solvate thereof. In formula (I), X represents a phenylene group, Y represents a hydrogen atom, -(CH2)mR1, or...  
WO/2012/004443A1
The invention relates to compounds which are active pharmaceutical principles used for treating and/or preventing inflammation and/or cancer, having formula (I) in which -X- is a single bond, -NH- or -CO-, and -Ar is an aromatic radical ...  
WO/2011/012247A8
Described are 2-(3-alkylthiobenzoyl)cyclohexanediones of the general formula (I) as herbicides. X, Y, R1 to R8 in this formula (I) stand for radicals such as hydrogen or organic radicals such as alkyl and alkoxy.  
WO/2011/161101A1
The invention relates to selective estrogen receptor modulators (SERMs) and to processes for production thereof, to the use thereof for treatment and/or prophylaxis of disorders, and to the use thereof for production of medicaments for t...  
WO/2011/158918A1
Disclosed is a novel polynuclear metal compound which is specific, has high catalytic properties, and has great potential as a novel functional material or the like. Specifically disclosed is a polynuclear metal compound which has at lea...  
WO/2011/154677A1
The present invention provides compounds of formula (I) in which, n, R1, R2 and Q are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.  
WO/2011/117324A3
A new process for making polyprenols is described as well as the use of these building blocks in the synthesis of Vitamin K2. The process involves reaction of a compound of formula (X) with a compound of formula (XI) in the presence of a...  
WO/2011/067649A3
The present invention provides a method for the preparation of polymer grade 4,4'-dichlorodiphenyl sulfone in steps comprising reacting dimethyl sulfate and sulfur trioxide optionally containing a catalyst; reacting the formed dimethyl p...  
WO/2011/131542A1
The invention relates to a method for producing products, characterized in that (A) at least one compound of general formula (I), where R1 is selected from hydrogen and C1-C4-alkyl, and a sulfonating agent are reacted with one another at...  
WO/2011/132171A1
The present invention relates to nitric oxide releasing prodrugs of known drugs or therapeutic agents which are represented herein as compounds of formula (I) wherein the drugs or therapeutic agents contain one or more functional groups ...  
WO/2011/131665A1
The invention relates to a method for producing 4,4'-dichlorodiphenyl sulfone from monochlorobenzene in which the maximum concentration of hydrocarbons containing 5 to 8 carbon atoms is 100 ppm relative to the total weight of the monochl...  
WO/2011/131508A1
The invention relates to a method for producing 4,4'-dichlorodiphenyl sulfone, comprising the reaction of monochlorobenzene with liquid sulfur trioxide that has a maximum boron concentration of 100 ppm relative to the total weight of the...  
WO/2011/129967A2
The description includes materials that may be useful for fuel cell applications such as in the manufacture of fuel cell electrodes, proton exchange membranes (PEM), as catalyst additives or in tie layers designed to be thermally and che...  
WO/2011/126099A1
A medication that has excellent agonist effects on CaSR and enables the prevention or treatment of diabetes or obesity is provided by means of compound represented by formula (I) defined in the description, or a composition comprising a ...  
WO/2011/107465A1
The invention relates to a method for producing 4-chlorobenzene sulphonic acid from 2-chlorobenzene sulphonic acid and/or 3-chlorobenzene sulphonic acid, comprising the reaction of 2-chlorobenzene sulphonic acid and/or 3-chlorobenzene su...  
WO/2011/101321A1
A description is given of 3-aminocarbonyl-substituted benzoylcyclo­hexanediones of the general formula (I) as herbicides. In this formula (I), R1 to R5 stand for radicals such as hydrogen, organic radicals such as alkyl, and other radic...  
WO/2011/102514A1
A compound represented by formula (I) [wherein each symbol is as defined in the description], a salt thereof, or a prodrug of the compound or the salt, which has an excellent inhibitory activity on long chain fatty acids family member 6 ...  
WO/2011/098985A1
The invention relates to compounds of formula (Formula III) (III) and of formula (Formula (IV) (IV), to methods for producing said compounds, and to the use thereof in the synthesis of saxagliptin.  

Matches 351 - 400 out of 10,959